PHARMA BULLETIN ⚕️
PHARMA UPDATES⚕️ (1)Bharat Biotech’s ROTAVAC 5D receives WHO pre-qualification. It's the only rotavirus vaccine in the world to be delivered in a 0.5 ml dose volume. Bharat Biotech has announced that the World Health Organization (WHO) has awarded pre-qualification to its rotavirus vaccine, ROTAVAC 5D. The new variant of ROTAVAC, ROTAVAC 5D, is a rotavirus vaccine formulation that can be administered without a buffer. Its low dose volume (0.5 mL) facilitates easy vaccine logistics, cold chain management and low biomedical waste disposal post-vaccination. It is used for the prevention of rotavirus infection, which is prevalent in infants and young children, the company said in a statement. (2)Glenmark inks agreement with SaNOtize to commercialise nasal spray for COVID-19 treatment in India and other Asian markets Nitric oxide (NO) has anti-microbial properties with a direct proven effect on SARS-CoV-2. Glenmark Pharmaceuticals and SaNOtize Research & Dev